Table 2.
Pathogens isolated in patients undergoing interventions for device infection from three large patient cohorts in North America, Europe, and Asia
| Percentage of isolates |
|||
|---|---|---|---|
| Pathogen | North America16 | Europe17 | Asia18 |
| Coagulase-negative staphylococci | 69 | 45.2 | |
| Methicillin-resistant | 18.8 | ||
| Methicillin-sensitive | 18.8 | ||
| S. aureus | 13.8 | 4.1 | |
| Methicillin-sensitive | 15.8 | ||
| Methicillin-resistant | 15.0 | ||
| Streptococcus spp. | 2.5 | ||
| Enterococcus spp. | |||
| Vancomycin-sensitive | 2.8 | ||
| Vancomycin-resistant | 1.4 | ||
| Cutibacterium spp. (previously Propionibacterium spp.) | 2.5 | ||
| Corynebacterium | 5 | ||
| Gram-negative bacteria | 8.9 | 6.1 | 9.1 |
| Enterobacteriaceae | 3 | 3.2 | |
| Non-fermentative bacilli, incl. Pseudomonas spp. | 1.5 | 5.9 | |
| Anaerobes | 1.6 | ||
| Fungi | 0.9 | 1 | 0.9 |
| Mycobacteria | 0.2 | ||